America’s cardiovascular burden from rising temperatures is set to nearly triple by 2050, with a new JAMA Cardiology study predicting thousands more CV deaths per year due to high-emissions and climate change.
https://t.co/1sXUbI7o9S
In the latest Cardiac Wire, we discuss…
🫀It’s Getting Hot in Here, So Watch Out for Your Heart
🫀@American_Heart and ATTR-CM Awareness
🫀@GetingeGlobal Launches New CABG Tech
And more cardiology news:
https://t.co/73bGftdE5r
Most microplastic research usually focuses on tissue build-up, but a new Circulation study suggests Bisphenol F (BPF) damages our heart muscle through an unexpected pathway in the gut.
https://t.co/65jUXXtOaI
In the latest Cardiac Wire, we discuss…
🫀One Microplastic’s Way to Your Heart is Through the Gut
🫀VNS Trial Discontinued
🫀Artivion’s Arch Tech Investment
And more cardiology news:
https://t.co/HNRVGIYZHG
Much like a beating heart, cardiology never stops. Regardless of platform, this list of top cardiology resources should keep you well-informed about one of healthcare’s most cutting-edge specialties.
https://t.co/Yym7ScEsCg
In the latest Cardiac Wire, we discuss…
🫀The 40 Best Cardiology Resources to Follow in 2026
🫀Retatrutide’s Historic Weight Loss
🫀VERVE-102’s Strong Early Results
And more cardiology news:
https://t.co/0eh4iIh5HE
Heart failure inflammation might actually be an underrecognized therapeutic target, after analysis of the POSEIDON registry found that systemic inflammation is present in nearly half of heart failure patients, regardless of ejection fraction.
https://t.co/2VTTurFkYK
In the latest Cardiac Wire, we discuss…
🫀Inflammation’s Prevalence and Role in Heart Failure
🫀BP in AFib and MACE
🫀@bostonsci’s MiRus Investment
And more cardiology news:
https://t.co/N2xHDeME0y
It might feel like a transcatheter alphabet soup out there with all of the valve interventions that have come out in the last few years, but Cardiac Wire is here to help make sense of it all.
https://t.co/kekZPJfuv0
In the latest Cardiac Wire, we discuss…
🫀Cardiac Wire’s State of The Transcatheter Valve
🫀BP in AFib and MACE
🫀Siemens’ Six FDA Wins
And more cardiology news:
https://t.co/3oLTsskLx9
Despite a TAVR popularity surge in recent years, a Vizient registry analysis suggests the procedure’s prevalence has stabilized in patients under 65, but there’s still significant debate on whether the young patient TAVR rate is appropriate.
https://t.co/Z1EICpIUGK
In the latest Cardiac Wire, we discuss…
🫀The Young TAVR Trend is Stabilizing
🫀Acoramidis’ Clinical Outcomes
🫀The eLym System for ADHF
And more cardiology news:
https://t.co/02YiES39uX
Data from a new Lancet study suggests that patients with chronic kidney disease might get similar cardiovascular protection from blood pressure drugs as the general population, giving physicians some certainty about how to approach BP in these patients.
https://t.co/GtVFCnKJT4